Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

安斯泰来制药集团是一家制药企业,业务遍及全球70多个国家和地区。目前,我们正在推进“焦点领域的研究策略(Focus Area Approach)”,旨在通过聚焦生理机制和治疗手段,确定持续研发新药的机会,解决尚未被满足的医疗需求。与此同时,我们正在将目光投向处方药以外的业务领域,将我们的专业技能和知识与不同领域外部合作伙伴的前沿技术相结合,打造Rx+®医疗解决方案。通过这些努力,安斯泰来立志处于不断变化的医疗行业的*前沿,将科学创新转变为患者的价值。

更多信息,请访问我们的网站



Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities fthe continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology Modality. Furthermore, we are also looking beyond our foundational Rx focus to Rx+® healthcare solutions that combine our expertise knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science value fpatients. Fmore information, please visit our website at 



关于安斯泰来中国

安斯泰来中国是安斯泰来制药集团在中国设立的全资公司,由安斯泰来(中国)投资有限公司(简称安斯泰来投资)、北京安斯泰来医药有限公司(简称北京安斯泰来医药)及安斯泰来制药(中国)有限公司(简称安斯泰来制药)组成。其中安斯泰来投资为公司在大中华区的区域总部,全资控股北京安斯泰来医药及安斯泰来制药。后两者分别为安斯泰来在中国市场的肿瘤及专科治疗产品营销中心以及药品生产制造中心。

安斯泰来自1994年进入中国,始终专注于尚未满足的医疗需求,以公开、诚信和协作的方式开展业务,全心全意向中国大众提供高质量的创新药品和服务,致力于提升中国社会的健康福祉。中国是安斯泰来全球增长战略中至关重要的一部分,目前,公司在中国市场销售的产品涉及肿瘤、移植免疫、泌尿、感染等多个专业治疗领域。

更多信息,请访问我们的网站

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

安斯泰来 How Fast Is Hiring Growing? (55 open positions)

Manage
Note: How fast is hiring at 安斯泰来(中国)投资有限公司 growing? 安斯泰来2025年98个(增长123%),2024年44个(增长159%),2023年17个(增长13%),2022年15个. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

安斯泰来 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 17%
  • 2024: Up 500%
  • 2023: Down 50%
安斯泰来 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 安斯泰来(中国)投资有限公司 growing? 安斯泰来历年硕士招聘职位量:2025年7个(增长17%),2024年6个(增长500%),2023年1个(下降50%),2022年2个. 安斯泰来在北京硕士人才需求中排名第284, 安斯泰来硕士工资大部分在30-50K以上.

安斯泰来 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 安斯泰来(中国)投资有限公司? Based on an analysis of 安斯泰来's job postings over the past year, “医疗卫生/美容保健类”需求占29.2%,“生物/制药/化工/环保类”占6.9%,“电子/电器/通信技术类”占6.9%,“计算机/网络/技术类”占2.8%,“机械/仪器仪表类”占1.4%. For reference only.

安斯泰来 — What Are the Salaries Like? (72 records)

Manage
安斯泰来 Salary Overview
salary range: 2K - 50K, 70.8% of roles pay ¥15-50K以上
Note: salary statistics are based on 72 salary records from the past year and depend on the job sample. For reference only.
安斯泰来(中国)投资有限公司工资待遇怎么样?安斯泰来70.8%的岗位拿15-50K以上,应届生工资¥。与同行业比+12%,销售类平均工资¥25.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 安斯泰来

(More)
Are salaries high at 安斯泰来(中国)投资有限公司? We provide: 医药代表,ea,te,ra,sa,医学联络官,ma,药品注册,msl,qa,oc,pe,pv,副总,培训,大区负责人,药学,bd,it专员,od. Click to view detailed salary analysis by job.

安斯泰来 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    52% of total 52%
  • 经营管理类
    14.8% of total 14.8%
  • 医疗卫生/美容保健类
    14.3% of total 14.3%
  • 工厂生产类
    12.8% of total 12.8%

Education

  • 本科
    49.5% of total 49.5%
  • 大专
    31.1% of total 31.1%
  • 硕士
    15.8% of total 15.8%
  • 不限
    3.1% of total 3.1%

Experience

  • 3-5年
    40.8% of total 40.8%
  • 5-10年
    29.6% of total 29.6%
  • 不限
    13.8% of total 13.8%
  • 1-3年
    13.3% of total 13.3%
View Detailed Analysis

What does 安斯泰来(中国)投资有限公司 require? Who is 安斯泰来 hiring? 安斯泰来招聘类别销售类占比最多占52%,其次是经营管理类占14.8%。安斯泰来什么学历能进?本科占比最多占49.5%,其次是大专占31.1%。安斯泰来学历要求高吗?硕士占15.8%,博士占0.5%。工作经验安斯泰来有什么要求?3-5年占比最多占40.8%,其次是5-10年占29.6%。安斯泰来工作地区在哪?北京占比最多占33.2%,其次是沈阳占13.3%。 Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 27,935.1114万(美元)
Legal Representative: 赵萍
Date Established:
Credit Code: 91110105MA04C7DH7R
Registered Address: 北京市朝阳区建国门外大街8号楼27层2302单元27010室

Talent Demand Trend Analysis More

Partners & Suppliers

国药控股分销安斯泰来的泌尿、感染药物 Source
合作客户 化学药
安斯泰来委托药明生物进行生物药工艺开发与生产 Source
供应商 CDMO

People who follow 安斯泰来 also follow

安斯泰来 Competitors (Similar Companies)

制药/药业 制药 中枢神经药 盐酸坦索罗辛
“致力于分子靶向药物和免疫肿瘤药物研发,及商业创新领域”
“全周期人身保险产品和服务”
“从事生物诊断试剂与疫苗研发及生产的高新技术企业”
文化科技
“经营健康,缔造光明”
“让每一个人因为健康而对百利充满信任和期待!”
驱动电机 新材料 有机硅 线束
“致力于研究、开发、生产及商业化全球病人可负担的创新抗体新药”
电气 微电机 风电设备 机电
“专注于中国血糖仪的普及推动及血糖管理事业的发展”
游乐设备 研发 连锁 销售
“专业化彩妆集团”
健康管理 职业健康 社区卫生服务 职业病防治

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

教育培训-其他
客服
由百度提供